The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 6, Issue 12, 1988, Pages 1838-1844

  Vose, J M ^a   Armitage, J O ^a   Weisenburger, D D ^a   Bierman, P J ^a   Sorensen, S ^a   Hutchins, M ^a   Moravec, D F ^a   Howe, D ^a   Dowling, M D ^a   Mailliard, J ^a   Johnson, P S ^a   Pevnick, W ^a   Packard, W M ^a   Okerbloom, J ^a   Thompson, R F ^a   Langdon Jr , R M ^a   Soori, G ^a   Peterson, C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGE; AGED; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEPSIS; SURVIVAL;

EID: 0024270189     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1988.6.12.1838     Document Type: Article

References (0)